Verax Biomedical has obtained European clearance for its Platelet PGD test, which is designed to rapidly spot bacterial contaminants in blood cells and tissue. The device, which has also secured 510(k) clearance from the FDA, could be used to boost the safety of the blood supply, the company said.

Related Summaries